Xinling Pharmaceutical

About Xinling Pharmaceutical

NovaStage Pharma specializes in the development of transdermal patch and oral film drug products designed to offer clinical advantages such as lower toxicity, higher efficacy, and better patient compliance compared to traditional oral tablets. The company targets unmet medical needs in both China and global markets, aiming to introduce several blockbuster drugs in the coming years. NovaStage Pharma's research pipeline includes a dozen US 505b2 and China Class II new drugs, many of which are anticipated to become major market successes. The company boasts a team of senior American experts and seasoned executives from the domestic pharmaceutical industry, bringing extensive experience in pharmaceutical product development. NovaStage Pharma generates revenue through the research, development, and eventual commercialization of its innovative drug products.